Protalix Biotherapeutics, Inc. (PLX)
2.04
-0.02
(-0.97%)
USD |
NYAM |
Jan 16, 16:00
2.05
+0.01
(+0.49%)
After-Hours: 20:00
Protalix Biotherapeutics EPS Diluted (Quarterly): 0.0291 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| OraSure Technologies, Inc. | -0.1878 |
| PAVmed, Inc. | -8.807 |
| Denali Therapeutics, Inc. | -0.736 |
| AIM ImmunoTech, Inc. | -1.567 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.355M |
| Revenue (Quarterly) | 17.85M |
| Total Expenses (Quarterly) | 15.50M |
| Enterprise Value | 142.87M |
| Gross Profit Margin (Quarterly) | 53.37% |
| Profit Margin (Quarterly) | 13.19% |
| Earnings Yield | 3.41% |
| Operating Earnings Yield | 3.97% |
| Normalized Earnings Yield | 3.407 |